242 related articles for article (PubMed ID: 25800244)
41. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
Neumann HP; Pawlu C; Peczkowska M; Bausch B; McWhinney SR; Muresan M; Buchta M; Franke G; Klisch J; Bley TA; Hoegerle S; Boedeker CC; Opocher G; Schipper J; Januszewicz A; Eng C;
JAMA; 2004 Aug; 292(8):943-51. PubMed ID: 15328326
[TBL] [Abstract][Full Text] [Related]
42. Clinical characteristics of pheochromocytoma patients with germline mutations in SDHD.
Dannenberg H; van Nederveen FH; Abbou M; Verhofstad AA; Komminoth P; de Krijger RR; Dinjens WN
J Clin Oncol; 2005 Mar; 23(9):1894-901. PubMed ID: 15774781
[TBL] [Abstract][Full Text] [Related]
43. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia.
Gill AJ
Pathology; 2012 Jun; 44(4):285-92. PubMed ID: 22544211
[TBL] [Abstract][Full Text] [Related]
44. Screening of mutations in genes that predispose to hereditary paragangliomas and pheochromocytomas.
Lefebvre S; Borson-Chazot F; Boutry-Kryza N; Wion N; Schillo F; Peix JL; Brunaud L; Finat A; Calender A; Giraud S
Horm Metab Res; 2012 May; 44(5):334-8. PubMed ID: 22517554
[TBL] [Abstract][Full Text] [Related]
45. Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility.
Astuti D; Ricketts CJ; Chowdhury R; McDonough MA; Gentle D; Kirby G; Schlisio S; Kenchappa RS; Carter BD; Kaelin WG; Ratcliffe PJ; Schofield CJ; Latif F; Maher ER
Endocr Relat Cancer; 2011 Feb; 18(1):73-83. PubMed ID: 20959442
[TBL] [Abstract][Full Text] [Related]
46. Clinical Predictors of Malignancy in Patients with Pheochromocytoma and Paraganglioma.
Dhir M; Li W; Hogg ME; Bartlett DL; Carty SE; McCoy KL; Challinor SM; Yip L
Ann Surg Oncol; 2017 Nov; 24(12):3624-3630. PubMed ID: 28884434
[TBL] [Abstract][Full Text] [Related]
47. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
Zbar B
Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521
[TBL] [Abstract][Full Text] [Related]
48. VHL disease.
Barontini M; Dahia PL
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):401-13. PubMed ID: 20833332
[TBL] [Abstract][Full Text] [Related]
49. Genotype-phenotype correlations, and retinal function and structure in von Hippel-Lindau disease.
Wittström E; Nordling M; Andréasson S
Ophthalmic Genet; 2014 Jun; 35(2):91-106. PubMed ID: 24555745
[TBL] [Abstract][Full Text] [Related]
50. Genetics of pheochromocytoma and paraganglioma in Spanish patients.
Cascón A; Pita G; Burnichon N; Landa I; López-Jiménez E; Montero-Conde C; Leskelä S; Leandro-García LJ; Letón R; Rodríguez-Antona C; Díaz JA; López-Vidriero E; González-Neira A; Velasco A; Matias-Guiu X; Gimenez-Roqueplo AP; Robledo M
J Clin Endocrinol Metab; 2009 May; 94(5):1701-5. PubMed ID: 19258401
[TBL] [Abstract][Full Text] [Related]
51. Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients.
Bayley JP; Weiss MM; Grimbergen A; van Brussel BT; Hes FJ; Jansen JC; Verhoef S; Devilee P; Corssmit EP; Vriends AH
Endocr Relat Cancer; 2009 Sep; 16(3):929-37. PubMed ID: 19546167
[TBL] [Abstract][Full Text] [Related]
52. Germinal mutations of RET, SDHB, SDHD, and VHL genes in patients with apparently sporadic pheochromocytomas and paragangliomas.
Krawczyk A; Hasse-Lazar K; Pawlaczek A; Szpak-Ulczok S; Krajewska J; Paliczka-Cieślak E; Jurecka-Lubieniecka B; Roskosz J; Chmielik E; Ziaja J; Cierpka L; Peczkowska M; Preibisz A; Januszewicz A; Otto M; Jarzab B
Endokrynol Pol; 2010; 61(1):43-8. PubMed ID: 20205103
[TBL] [Abstract][Full Text] [Related]
53. Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas.
Yao L; Schiavi F; Cascon A; Qin Y; Inglada-Pérez L; King EE; Toledo RA; Ercolino T; Rapizzi E; Ricketts CJ; Mori L; Giacchè M; Mendola A; Taschin E; Boaretto F; Loli P; Iacobone M; Rossi GP; Biondi B; Lima-Junior JV; Kater CE; Bex M; Vikkula M; Grossman AB; Gruber SB; Barontini M; Persu A; Castellano M; Toledo SP; Maher ER; Mannelli M; Opocher G; Robledo M; Dahia PL
JAMA; 2010 Dec; 304(23):2611-9. PubMed ID: 21156949
[TBL] [Abstract][Full Text] [Related]
54. Testing new susceptibility genes in the cohort of apparently sporadic phaeochromocytoma/paraganglioma patients with clinical characteristics of hereditary syndromes.
Pęczkowska M; Kowalska A; Sygut J; Waligórski D; Malinoc A; Janaszek-Sitkowska H; Prejbisz A; Januszewicz A; Neumann HP
Clin Endocrinol (Oxf); 2013 Dec; 79(6):817-23. PubMed ID: 23551045
[TBL] [Abstract][Full Text] [Related]
55. Rationalization of genetic testing in patients with apparently sporadic pheochromocytoma/paraganglioma.
Cascón A; López-Jiménez E; Landa I; Leskelä S; Leandro-García LJ; Maliszewska A; Letón R; de la Vega L; García-Barcina MJ; Sanabria C; Alvarez-Escolá C; Rodríguez-Antona C; Robledo M
Horm Metab Res; 2009 Sep; 41(9):672-5. PubMed ID: 19343621
[TBL] [Abstract][Full Text] [Related]
56. Frequent genetic changes in childhood pheochromocytomas.
De Krijger RR; Petri BJ; Van Nederveen FH; Korpershoek E; De Herder WW; De Muinck Keizer-Schrama SM; Dinjens WN
Ann N Y Acad Sci; 2006 Aug; 1073():166-76. PubMed ID: 17102083
[TBL] [Abstract][Full Text] [Related]
57. A novel RET gene mutation in a patient with apparently sporadic pheochromocytoma.
Scollo C; Russo M; De Gregorio L; Terranova R; Mangione E; Castoro C; Squatrito S; Pellegriti G
Endocr J; 2016; 63(1):87-91. PubMed ID: 26497911
[TBL] [Abstract][Full Text] [Related]
58. Pheochromocytoma: an update on genetics and management.
Karagiannis A; Mikhailidis DP; Athyros VG; Harsoulis F
Endocr Relat Cancer; 2007 Dec; 14(4):935-56. PubMed ID: 18045948
[TBL] [Abstract][Full Text] [Related]
59. First report of bilateral pheochromocytoma in the clinical spectrum of HIF2A-related polycythemia-paraganglioma syndrome.
Taïeb D; Yang C; Delenne B; Zhuang Z; Barlier A; Sebag F; Pacak K
J Clin Endocrinol Metab; 2013 May; 98(5):E908-13. PubMed ID: 23539726
[TBL] [Abstract][Full Text] [Related]
60. Long-term prognosis of patients with pediatric pheochromocytoma.
Bausch B; Wellner U; Bausch D; Schiavi F; Barontini M; Sanso G; Walz MK; Peczkowska M; Weryha G; Dall'igna P; Cecchetto G; Bisogno G; Moeller LC; Bockenhauer D; Patocs A; Rácz K; Zabolotnyi D; Yaremchuk S; Dzivite-Krisane I; Castinetti F; Taieb D; Malinoc A; von Dobschuetz E; Roessler J; Schmid KW; Opocher G; Eng C; Neumann HP
Endocr Relat Cancer; 2014 Feb; 21(1):17-25. PubMed ID: 24169644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]